Results Snapshot
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 161.00% vs -69.68% in Dec 2024
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 468.66% vs -71.27% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 418.11% vs -63.86% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 159.38% vs 45.45% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Shukra Pharma. With
Nine Monthly - Net Sales
YoY Growth in nine months ended Dec 2025 is 161.00% vs -69.68% in Dec 2024
Nine Monthly - Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 468.66% vs -71.27% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
YoY Growth in nine months ended Dec 2025 is 418.11% vs -63.86% in Dec 2024
Nine Monthly - Interest
YoY Growth in nine months ended Dec 2025 is 159.38% vs 45.45% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024






